214 related articles for article (PubMed ID: 14511258)
1. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis of asbestosis in the 21
Carney JM; Sporn TA; Roggli VL; Pavlisko EN
Ultrastruct Pathol; 2024 Mar; 48(2):137-148. PubMed ID: 38192052
[TBL] [Abstract][Full Text] [Related]
3. Chronological trends in the causation of malignant mesothelioma: Fiber burden analysis of 619 cases over four decades.
Roggl VL; Green CL; Liu B; Carney JM; Glass CH; Pavlisko EN
Environ Res; 2023 Aug; 230():114530. PubMed ID: 36965800
[TBL] [Abstract][Full Text] [Related]
4. Mortality rates from asbestos-related diseases in Italy during the first year of the COVID-19 pandemic.
Fazzo L; Grande E; Zona A; Minelli G; Crialesi R; Iavarone I; Grippo F
Front Public Health; 2023; 11():1243261. PubMed ID: 38292377
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.
Angelico G; Caltabiano R; Loreto C; Ieni A; Tuccari G; Ledda C; Rapisarda V
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495596
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients.
Kishimoto T; Fujimoto N; Ebara T; Omori T; Oguri T; Niimi A; Yokoyama T; Kato M; Usami I; Nishio M; Yoshikawa K; Tokuyama T; Tamura M; Yokoyama Y; Tsuboi K; Matsuo Y; Xu J; Takahashi S; Abdelgied M; Alexander WT; Alexander DB; Tsuda H
BMC Cancer; 2019 Dec; 19(1):1204. PubMed ID: 31823764
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridisation in malignant deciduoid mesothelioma.
Scattone A; Pennella A; Gentile M; Musti M; Nazzaro P; Buonadonna AL; Marzullo A; Cavone D; Pollice L; Serio G
J Clin Pathol; 2006 Jul; 59(7):764-9. PubMed ID: 16569690
[TBL] [Abstract][Full Text] [Related]
8. Detailed clinical course of a patient with rapidly progressing sarcomatoid pleural mesothelioma without p16 deletion with systemic haematogenous metastasis to soft tissues.
Mizuhashi K; Okamoto K; Nabeshima K; Kishimoto T
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38341199
[TBL] [Abstract][Full Text] [Related]
9. Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
van Pel DM; Cheung S; Ionescu DN; Churg A
Hum Pathol; 2023 Nov; 141():64-68. PubMed ID: 37776956
[TBL] [Abstract][Full Text] [Related]
10. Primary omental mesothelioma: a rare but important differential diagnosis in previous asbestos exposure.
Harb A; King E; Lloyd H; Harb Z; Payne JG
J Gastrointest Surg; 2010 Feb; 14(2):423-5. PubMed ID: 19424765
[TBL] [Abstract][Full Text] [Related]
11. Position Paper on Asbestos of the Italian Society of Occupational Medicine.
Apostoli P; Boffetta P; Bovenzi M; Cocco PL; Consonni D; Cristaudo A; Discalzi G; Farioli A; Manno M; Mattioli S; Pira E; Soleo L; Taino G; Violante FS; Zocchetti C
Med Lav; 2019 Dec; 110(6):459-485. PubMed ID: 31846450
[TBL] [Abstract][Full Text] [Related]
12. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma.
Nakagiri T; Amatya VJ; Kushitani K; Kambara T; Aoe K; Endo I; Miyata Y; Okada M; Takeshima Y
Am J Surg Pathol; 2024 Feb; 48(2):140-149. PubMed ID: 37899530
[TBL] [Abstract][Full Text] [Related]
13. Asbestos burden in lungs of mesothelioma patients with pleural plaques, lung fibrosis and/or ferruginous bodies at histology: a postmortem SEM-EDS study.
Visonà SD; Bertoglio B; Capella S; Belluso E; Austoni B; Colosio C; Kurzhunbaeva Z; Ivic-Pavlicic T; Taioli E
Carcinogenesis; 2024 Mar; 45(3):131-139. PubMed ID: 38069464
[TBL] [Abstract][Full Text] [Related]
14. Asbestos-related cancer in naval personnel: findings from participants in the British nuclear tests 1952-1967.
Gun RT; Kendall GM
Sci Rep; 2023 Nov; 13(1):18842. PubMed ID: 37963950
[TBL] [Abstract][Full Text] [Related]
15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-1971.
N Engl J Med; 1971 Apr; 284(14):778-86. PubMed ID: 5548036
[No Abstract] [Full Text] [Related]
16. Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions.
Alcala N; Mangiante L; Le-Stang N; Gustafson CE; Boyault S; Damiola F; Alcala K; Brevet M; Thivolet-Bejui F; Blanc-Fournier C; Le Rochais JP; Planchard G; Rousseau N; Damotte D; Pairon JC; Copin MC; Scherpereel A; Wasielewski E; Wicquart L; Lacomme S; Vignaud JM; Ancelin G; Girard C; Sagan C; Bonnetaud C; Hofman V; Hofman P; Mouroux J; Thomas de Montpreville V; Clermont-Taranchon E; Mazieres J; Rouquette I; Begueret H; Blay JY; Lantuejoul S; Bueno R; Caux C; Girard N; McKay JD; Foll M; Galateau-Salle F; Fernandez-Cuesta L
EBioMedicine; 2019 Oct; 48():191-202. PubMed ID: 31648983
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma.
Akarsu M; Ak G; Dündar E; Metintaş M
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7767-7778. PubMed ID: 37027032
[TBL] [Abstract][Full Text] [Related]
18. The over diagnosis of diffuse mesothelioma: An analysis of 311 cases with recommendations for the avoidance of pitfalls.
Carney JM; Roggli VL; Glass CH; Piña-Oviedo S; Pavlisko EN
Ann Diagn Pathol; 2024 Feb; 68():152248. PubMed ID: 38182448
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-199/214 is a distinctive feature of iron-induced and asbestos-induced sarcomatoid mesothelioma in rats.
Okazaki Y; Chew SH; Nagai H; Yamashita Y; Ohara H; Jiang L; Akatsuka S; Takahashi T; Toyokuni S
Cancer Sci; 2020 Jun; 111(6):2016-2027. PubMed ID: 32248600
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos.
Kumagai-Takei N; Yamamoto S; Lee S; Maeda M; Masuzzaki H; Sada N; Yu M; Yoshitome K; Nishimura Y; Otsuki T
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
